Q4 2024 Holdings
Filed 2025-02-14 | 34 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $301.0M | 1,038,550 | 18.2% |
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $160.8M | 2,798,830 | 9.7% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $137.6M | 4,074,419 | 8.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $133.5M | 5,000,000 | 8.1% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $114.9M | 165,836 | 7.0% |
| Salesforce Inc(CRM) | COM | 79466L302 | $98.3M | 293,901 | 5.9% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $68.4M | 10,114,633 | 4.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $62.0M | 1,500,000 | 3.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $61.4M | 750,000 | 3.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $50.0M | 724,666 | 3.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $49.1M | 960,215 | 3.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $43.1M | 2,250,000 | 2.6% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $40.5M | 1,520,627 | 2.5% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $38.4M | 452,327 | 2.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $33.1M | 1,725,000 | 2.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $32.2M | 490,000 | 1.9% |
| Merus N V | COM | N5749R100 | $31.5M | 750,000 | 1.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $25.3M | 1,000,000 | 1.5% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $24.0M | 1,663,724 | 1.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $23.6M | 2,500,000 | 1.4% |
| Lanzatech Global Inc | COM | 51655R101 | $21.7M | 15,814,845 | 1.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.3M | 175,000 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.8M | 1,100,000 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $13.5M | 2,400,000 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $13.1M | 1,600,000 | 0.8% |
| Ceribell Inc.(CBLL) | COM | 15678C102 | $8.5M | 328,809 | 0.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $8.4M | 1,500,000 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $7.4M | 1,122,581 | 0.4% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $6.9M | 1,850,000 | 0.4% |
| Mersana Therapeutics Inc. | COM | 59045L106 | $6.1M | 4,250,000 | 0.4% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $3.3M | 1,126,915 | 0.2% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $3.1M | 3,354,449 | 0.2% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $1.7M | 441,558 | 0.1% |
| Galecto Inc(GLTO) | COM NEW | 36322Q206 | $464.6K | 99,913 | 0.0% |